Learn About Pediatric Growth Hormone Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
M Health Fairview Pediatric Specialty Clinic - Journey
Bradley Miller is a Pediatric Endocrinologist in Minneapolis, MN. Dr. Miller is rated as an Elite provider by MediFind in the treatment of Pediatric Growth Hormone Deficiency. His top areas of expertise are Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency, Hypopituitarism, Adrenoleukodystrophy (ALD), and Hormone Replacement Therapy (HRT).
Paul Saenger is a Pediatric Endocrinologist in Mineola, New York. Dr. Saenger is rated as an Elite provider by MediFind in the treatment of Pediatric Growth Hormone Deficiency. His top areas of expertise are Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Small for Gestational Age, Short Stature (Growth Disorders), and Hormone Replacement Therapy (HRT).
Lawrence Silverman is a Pediatric Endocrinologist in Morristown, New Jersey. Dr. Silverman is rated as an Elite provider by MediFind in the treatment of Pediatric Growth Hormone Deficiency. His top areas of expertise are Precocious Puberty, Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), and Idiopathic Short Stature (ISS).
Summary: The purpose of this study is to learn about the safety of Somatrogon for the treatment of pediatric growth hormone deficiency (p GHD) in India. Pediatric GHD is a condition caused by too less amounts of growth hormone in the body. Children with GHD have a short height. GHD can be present at birth or develop later. The condition occurs if the pituitary gland makes too little growth hormone. This is...
Summary: This is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD) in naive to treatment children and validate a predictive enrichment marker (PEM) strategy to select subjects likely to respond to therapy with LUM-201.